Short answer
CONMED Corp (CNMD) filed an 8-K current report with the SEC on July 29, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). CONMED reported fiscal second-quarter results for the period ended June 30, 2026.
CONMED Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- CONMED reported fiscal second-quarter results for the period ended June 30, 2026
- Press release issued July 29, 2026, with detailed financial results in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- Q2 sales $343.5M, up 0.3% reported but down 0.5% constant currency, reflecting GI exits and portfolio restructuring
- Organic constant-currency sales grew 6.0%, led by Orthopedic Surgery and international growth of 9.9%
- Adjusted diluted EPS $1.38, up 20.0%, while GAAP EPS reached $0.77, up 11.6%, including $0.21 tariff-refund benefit
- Gross margin expanded to 57.5% from 55.0%, but operating margin declined to 10.6% from 11.1% amid transition and rationalization costs
- Full-year adjusted EPS guidance raised to $4.48-$4.60 from $4.30-$4.45, while sales guidance narrowed to $1,358M-$1,373M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CONMED Corp 8-K filings
Get the next CNMD 8-K as it lands
Follow CNMD for push alerts, or ask the research agent what this filing means.